AS
Ascendis Pharma
ASND · NASDAQ
$270.09 +2.24% (+$5.93)
1M +5.66%
Market Cap 14.4B €
P/E Ratio 19.08x
Div. Yield -
ROE 190.44%
Bulios Fair Price
$231.32
14.4% downside
Trenutna cena
$270.09
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ASND trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
19 /100
Expensive P/E 19.08x
EV/EBITDA 179.99x
P/S 13.68x
Growth
100 /100
Growing Rev. growth 138.21%
EPS growth N/A
FCF growth N/A
Profitability
83 /100
Strong Gross margin 90.19%
Net margin 71.69%
Op. margin 10.38%
Quality
91 /100
Excellent ROIC 43.39%
ROE 190.44%
ROA 33.08%
Debt
81 /100
Low Debt/Equity 0.31x
Current ratio 2.99x
Int. coverage 0.37x
Stability
42 /100
Moderate Beta 0.38x
Rev. volatility 208.39%
EPS volatility 14.08%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ASND
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jan Moller Mikkelsen
Employees
1,189
Headquarters
Hellerup
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report